- Home
- ATRO vs ZVRA Comparison
ATRO vs ZVRA Comparison
Compare ATRO & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRO
- ZVRA
- Stock Information
- Founded
- ATRO 1968
- ZVRA 2006
- Country
- ATRO United States
- ZVRA United States
- Employees
- ATRO N/A
- ZVRA N/A
- Industry
- ATRO Military/Government/Technical
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- ATRO Industrials
- ZVRA Health Care
- Exchange
- ATRO Nasdaq
- ZVRA Nasdaq
- Market Cap
- ATRO 591.7M
- ZVRA 511.6M
- IPO Year
- ATRO N/A
- ZVRA 2015
- Fundamental
- Price
- ATRO $16.32
- ZVRA $8.48
- Analyst Decision
- ATRO Hold
- ZVRA Strong Buy
- Analyst Count
- ATRO 1
- ZVRA 7
- Target Price
- ATRO $20.00
- ZVRA $21.20
- AVG Volume (30 Days)
- ATRO 570.5K
- ZVRA 443.1K
- Earning Date
- ATRO 11-06-2024
- ZVRA 11-12-2024
- Dividend Yield
- ATRO N/A
- ZVRA N/A
- EPS Growth
- ATRO N/A
- ZVRA N/A
- EPS
- ATRO N/A
- ZVRA N/A
- Revenue
- ATRO $782,178,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- ATRO $15.70
- ZVRA N/A
- Revenue Next Year
- ATRO $6.98
- ZVRA $376.61
- P/E Ratio
- ATRO N/A
- ZVRA N/A
- Revenue Growth
- ATRO 19.95
- ZVRA 47.85
- 52 Week Low
- ATRO $14.13
- ZVRA $4.20
- 52 Week High
- ATRO $23.74
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- ATRO 47.04
- ZVRA 42.22
- Support Level
- ATRO $15.90
- ZVRA $8.35
- Resistance Level
- ATRO $16.73
- ZVRA $8.79
- Average True Range (ATR)
- ATRO 0.63
- ZVRA 0.37
- MACD
- ATRO 0.09
- ZVRA -0.13
- Stochastic Oscillator
- ATRO 92.16
- ZVRA 13.61
About ATRO Astronics Corporation
Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.